Results 231 to 240 of about 19,015 (246)

Semaglutide in Diabetic Kidney Disease: Integrating Clinical Evidence with Mechanistic Insights. [PDF]

Healthcare (Basel)
Bin Dayel FF.
europepmc   +1 more source

Optic disc edema during semaglutide therapy: case report and literature review. [PDF]

Am J Ophthalmol Case Rep
Yang T, Chen A, Zeng F, Liu J, Kamilijiang Y, Yuan B, Lu Y, Jin G.   +7 more
europepmc   +1 more source

Best of United European Gastroenterology Week 2025

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
Iuliana Nenu, Sara Nikolic, Eduardo Valdivielso, Giovanni Marasco   +3 more
wiley   +1 more source

PIONEER REAL Saudi Arabia: A multicentre, prospective, real-world study of once-daily oral semaglutide use in adults with type 2 diabetes in Saudi Arabia. [PDF]

Diabetes Obes Metab
ElBadawi H, Albalkhi N, Al Kadhim I, Elsadig A, Baltzis D, Hatahet MH, Ismail M, Khader S, Rasmussen CL, Scheuer SH, Shalaby A, Almehthel M.   +11 more
europepmc   +1 more source

Pharmacological progress in obesity: tirzepatide's rising advantage over semaglutide. [PDF]

Ann Med Surg (Lond)
Khan S, Afridi H, Mahato RK, Zubair M, Khan U, Ullah S.   +5 more
europepmc   +1 more source

The Effect of Semaglutide With Lifestyle Intervention on the Physical Health of Patients Treated With Antipsychotic Drugs in a Secure Mental Health Setting: Protocol for an Uncontrolled Pretest-Posttest Pilot Mixed Methods Study.

JMIR Res Protoc
Brenisin K, Kinnafick F, King J, Millard L, Arya D, Hodgson E, Huggins M, Simmons-Roberts A, O'Dowd M, Rayment N, Shah P, Breen KC.   +11 more
europepmc   +1 more source